<?xml version="1.0" encoding='utf-8' ?>
<nspnews type="text">
<version>v8.0</version>
<date>2024-05-10 16:34:46</date>
<action>I</action>
<registdate>2024-05-10 16:07:46</registdate>
<modifydate>2024-05-10 16:28:29</modifydate>
<publishdate>2024-05-10 16:34:41</publishdate>
<embargo>N</embargo>
<newsid>697911</newsid>
<orgid></orgid>
<language>KR</language>
<category1>21</category1>
<category2>2102</category2>
<category1_name>의학/건강</category1_name>
<category2_name>제약/바이오</category2_name>
<statusID>1</statusID>
<saleID>N</saleID>
<formatID>1</formatID>
<typeID>7</typeID>
<newsSubject><![CDATA[[업앤다운]제약주 상승…한국유니온제약↑·에스씨엠생명과학↓]]></newsSubject>
<newsSummary><![CDATA[]]></newsSummary>
<newsTag><![CDATA[한국유니온제약(080720),에스씨엠생명과학(298060),제약주,코스피,코스닥]]></newsTag>
<newsLinks><![CDATA[]]></newsLinks>
<news_prolog><![CDATA[(서울=NSP통신) 이복현 기자 =]]></news_prolog>
<news1><![CDATA[10일 코스피(+0.57%)와 코스닥(-0.69%)이 서로 엇갈린 가운데 제약주(+0.31%)는 상승했다. 상승주는 74개였고 하락주는 86개였다.

오늘 제약주 중에서는 한국유니온제약의 상승률이 가장 높았다. 한국유니온제약은 전일대비 7.06%(410원) 올라 6220원에 장을 마감했다. 한국유니온제약은 4월26일부터 하락세(5월3일 보합)를 이어오다 오늘 반등했다. 

또 에이비온(+6.36%) 에이프로젠바이오로직스(+5.84%) 광동헬스바이오(+4.03%) 대봉엘에스(+3.98%) 네오이뮨텍(+3.50%) 코스맥스비티아이(+2.93%) 콜마비앤에이치(+2.92%) 에이프로젠(+2.84%) 이연제약(+2.75%) 등이 상승했다. 

반면 에스씨엠생명과학의 하락률이 컸다. 에스씨엠생명과학은 전일대비 13.47%(425원) 내려 2795원에 장을 마감했다. 에스씨엠생명과학은 6거래일연속 상승세를 멈추고 하락했다. 

또 엔지켐생명과학(-11.56%) 카이노스메드(-6.82%) 대동고려삼(-5.20%) 휴메딕스(-4.52%) 티움바이오(-4.38%) HLB(-4.36%) 바이젠셀(-4.17%) HLB생명과학(-4.06%) 휴온스(-3.97%) 폴라리스AI파마(-3.93%) 등이 하락했다.]]></news1>
<news2_title><![CDATA[]]></news2_title>
<news2><![CDATA[]]></news2>
<news3_title><![CDATA[]]></news3_title>
<news3><![CDATA[]]></news3>
<news4_title><![CDATA[]]></news4_title>
<news4><![CDATA[]]></news4>
<news5_title><![CDATA[]]></news5_title>
<news5><![CDATA[]]></news5>
<news_epilog_info><![CDATA[]]></news_epilog_info>
<news_epilog_byline><![CDATA[NSP통신 이복현 기자(bhlee2016@nspna.com)]]></news_epilog_byline>
<news_epilog><![CDATA[ⓒ한국의 경제뉴스통신사 NSP통신·NSP TV. 무단전재-재배포 및 AI학습 이용 금지.]]></news_epilog>
<imageL><![CDATA[https://file.nspna.com/news/2024/05/10/20240510161034_697911_0.jpg]]></imageL>
<imageP><![CDATA[https://file.nspna.com/news/2024/05/10/photo_20240510161034_697911_0.jpg]]></imageP>
<image1><![CDATA[https://file.nspna.com/news/2024/05/10/20240510161034_697911_1.jpg]]></image1>
<image2><![CDATA[]]></image2>
<image3><![CDATA[]]></image3>
<image4><![CDATA[]]></image4>
<image5><![CDATA[]]></image5>
<image1_place><![CDATA[l]]></image1_place>
<image2_place><![CDATA[c]]></image2_place>
<image3_place><![CDATA[c]]></image3_place>
<image4_place><![CDATA[c]]></image4_place>
<image5_place><![CDATA[c]]></image5_place>
<image1_text><![CDATA[]]></image1_text>
<image2_text><![CDATA[]]></image2_text>
<image3_text><![CDATA[]]></image3_text>
<image4_text><![CDATA[]]></image4_text>
<image5_text><![CDATA[]]></image5_text>
<image1_source><![CDATA[]]></image1_source>
<image2_source><![CDATA[]]></image2_source>
<image3_source><![CDATA[]]></image3_source>
<image4_source><![CDATA[]]></image4_source>
<image5_source><![CDATA[]]></image5_source>
<vodSite><![CDATA[]]></vodSite>
<vodID><![CDATA[]]></vodID>
<vodTitle><![CDATA[]]></vodTitle>
<vodWidth><![CDATA[]]></vodWidth>
<vodHeight><![CDATA[]]></vodHeight>
<advertorial><![CDATA[]]></advertorial>
<location><![CDATA[서울]]></location>
<teamID>107</teamID>
<teamName><![CDATA[의학건강부]]></teamName>
<writerID>bhlee2016</writerID>
<writerName><![CDATA[이복현]]></writerName>
<writerTitle><![CDATA[기자]]></writerTitle>
<writerEmail><![CDATA[bhlee2016@nspna.com]]></writerEmail>
<writerID2></writerID2>
<writerName2><![CDATA[]]></writerName2>
<writerTitle2><![CDATA[]]></writerTitle2>
<writerEmail2><![CDATA[]]></writerEmail2>
<writerID3></writerID3>
<writerName3><![CDATA[]]></writerName3>
<writerTitle3><![CDATA[]]></writerTitle3>
<writerEmail3><![CDATA[]]></writerEmail3>
</nspnews>
